Genocea Biosciences Inc EBIT margin
Was ist das EBIT margin von Genocea Biosciences Inc?
EBIT margin von Genocea Biosciences Inc ist -1,902.09%
Was ist die Definition von EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Genocea Biosciences Inc
Was macht Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Unternehmen mit ebit margin ähnlich Genocea Biosciences Inc
- Field Trip Health hat EBIT margin von -1,986.17%
- Birla Tyres hat EBIT margin von -1,964.48%
- Adamis Pharmaceuticals hat EBIT margin von -1,957.91%
- Oncternal Therapeutics hat EBIT margin von -1,948.70%
- Serve Robotics Inc hat EBIT margin von -1,938.49%
- AC Immune SA hat EBIT margin von -1,923.84%
- Genocea Biosciences Inc hat EBIT margin von -1,902.09%
- Mirati Therapeutics Inc hat EBIT margin von -1,899.99%
- Cyclo Therapeutics hat EBIT margin von -1,831.29%
- Playgon Games hat EBIT margin von -1,811.96%
- ERYTECH Pharma S.A hat EBIT margin von -1,809.54%
- Celldex Therapeutics hat EBIT margin von -1,809.40%
- Zoetic International Plc hat EBIT margin von -1,802.73%